News | Cancer

Feature

Spilling the beans on the health impacts of coffee

On average, 98 million cups of coffee are consumed each day in the UK. Is this popular drink harmful or do its benefits outweigh its risks?…

Published: 14 April 2022

News

Antihistamines could improve outcomes for people with cancer undergoing immunotherapy

Researchers at the MD Anderson Cancer Center at the University of Texas said their results support the use of antihistamines to treat people with cancer who have an allergy with high levels of plasma histamine.…

Published: 24 November 2021

News

Study results show blood test could predict treatment response in people with prostate cancer

Researchers looked at circulating tumour cells in blood samples to identify changes in response to chemotherapy treatment.…

Published: 16 November 2021

Opinion

Clearing the COVID-19 patient treatment backlog through advancing efficient and safe delivery of care

Views from fellow pharmacists and nurses about cancer care and treatment.…

Published: 26 October 2021

Promotional content

News

Break in cancer treatment cuts side effects and does not affect life expectancy, study finds

A trial has shown that breaks from first-line treatments for patients with metastatic and/or locally advanced kidney cancer did not cause meaningful detriment to their life expectancy or quality of life.…

Published: 22 September 2021

News

NHS patients will be first in Europe to receive mutation-targeting lung cancer treatment

The tumour-agnostic drug sotorasib has been approved for the treatment of patients in England with non-small cell lung cancer.…

Published: 10 September 2021

Opinion

Chemotherapy is harming the environment: it is time for regulators, manufacturers and pharmacy to take action

Healthcare inevitably contributes to the global carbon footprint, but a more focused effort is needed to minimise the environmental impact of cancer chemotherapy.…

Published: 14 June 2021

News

CAR-T therapy extends remission in relapsed multiple myeloma patients

Median progression-free survival for patients treated with a new type of chimeric antigen receptor T-cell therapy was 8.8 months overall, increasing to 12.1 months for those treated with the maximum dose.…

Published: 13 May 2021

News

Statins may protect heart from breast cancer chemotherapy

Researchers concluded that statins may be a potential intervention for preventing heart failure in patients receiving chemotherapy.…

Published: 4 March 2021

News

New drug cuts the risk of death in bladder cancer by 30% compared with chemotherapy, study suggests

A trial comparing new antibody-drug conjugate enfortumab vedotin with chemotherapy in patients with bladder cancer has found that overall survival was longer in the group receiving the new drug.…

Published: 18 February 2021